Current Trends in Collaborative Drug Research: Leveraging target validation data to create valuable partnerships – Feb. 16, 2022
During this session our speakers will present and discuss the significance of target validation for early-stage drug discovery and development in academic settings using adMare BioInnovations and U of T IPO approaches (e.g., Bright Angel Therapeutics, Encycle Therapeutics, Zucara Therapeutics). You will learn how target validation increases likelihood of success in the clinic, important considerations during […]